Stay updated on Nivolumab and Axitinib in RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.

Latest updates to the Nivolumab and Axitinib in RCC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedLocations section consolidated under a single Locations heading, listing Maryland, New York, and Pennsylvania. Previous separate subsections for Maryland Locations, New York Locations, and Pennsylvania Locations were removed.SummaryDifference0.4%

- Check21 days agoNo Change Detected
- Check43 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check50 days agoChange DetectedThe government funding lapse notice about NIH operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedThe Study Record Dates section now includes additional update timestamps (e.g., 2025-10-29, 2026-04-06, 2026-10-06, 2025-10-28) and updates the label to Last Update Posted (Estimated).SummaryDifference0.8%

- Check93 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%

- Check100 days agoChange Detected- Updated the revision tag from v3.0.2 to v3.1.0, indicating a new version. No substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Axitinib in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.